Stock Taper 
TCG CROSSOVER MANAGEMENT, LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 CG Oncology Inc. | CGON | 3.67M | $260.77M |
 Relay Therapeutics, Inc. | RLAY | 4.27M | $79.95M |
 Immunovant, Inc. | IMVT | 4.46M | $171.77M |
 Dyne Therapeutics, Inc. | DYN | 4.62M | $102.5M |
 Monte Rosa Therapeutics, Inc. | GLUE | 4.62M | $111.86M |
 Cogent Biosciences, Inc. | COGT | 4.85M | $187.87M |
 Abivax S.A. | ABVX | 6.01M | $800.6M |
 Amylyx Pharmaceuticals, Inc. | AMLX | 6.24M | $112.14M |
 Tango Therapeutics, Inc. | TNGX | 9.08M | $283.88M |
 Aura Biosciences, Inc. | AURA | 9.53M | $67.69M |
 Altimmune, Inc. | ALT | 10M | $30.4M |
 BioCryst Pharmaceuticals, Inc. | BCRX | 11.02M | $110.21M |
 Editas Medicine, Inc. | EDIT | 11.11M | $36M |